Navigate Fool.com
Will SRDX beat
the market?

SurModics, Inc. (NASDAQ: SRDX)

Community Rating: 2 Stars: Unattractive

19.75 -0.28 (-1.40%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $20.02
Previous Close $20.03
Daily Range $19.66 - $20.06
52-Week Range $19.55 - $25.99
Market Cap $268.5M
P/E Ratio 22.01
Dividend (Yield) $0.00 (0.0%)
Volume 33,110
Average Daily Volume 60,439
Current FY EPS $0.89

How do you think SRDX
will perform against the market?

Top SRDX Bull/Bear Pitches


rklapman (< 20)
Submitted December 16, 2008

Expect takeover by JNJ

0 Replies Reply Report this Post

TMFCop (< 20)
Submitted April 14, 2009

Drug delivery unit derives most of its profits from JNJ stent business. The pharma just reported earnings that saw the stent business generate revenues that were down 28% in the U.S., 16% worldwide. O … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

SurModics Board Chairman Set to Step Down

New chairman will assume role at conclusion of annual shareholder meeting scheduled for February

Sector Update: Healthcare Shares Flat Pre-Market; ImmunoGen up 4% on Q4 Results

Sector Update: Healthcare

SurModics Announces Board Changes

SurModics Announces Organizational Changes

SurModics to Present at CL King’s Best Ideas Conference

SurModics's Earnings Beat Last Year's by 29%

Just the facts, Fool.

Here's How SurModics May Be Failing You

Keep your eye on margins.

SurModics Reports Third Quarter Fiscal 2013 Results

SurModics IVD Breakthrough Stabilizer Addresses Industry Challenge

See More SRDX News...





SurModics, Inc. (SRDX) Description

Develops, manufactures and markets innovative surface modification and drug delivery technologies for the healthcare industry. Website: http://www.surmodics.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks